6 December 2011
Aspirin therapy could benefit patients undergoing cardiac surgery, according to new research which showed that del the drug taken five days prior to surgery could decrease the risk of complications.
Scientists at Thomas Jefferson University and the University of California's Davis Medical Center found that complications associated with heart surgery such as renal failure and a long stay in intensive care could be bettered by the preoperative taking of aspirin.
Published in the journal Annals of Surgery, the findings showed that those who took the drug prior to an operation were less prone to the risk of a 30-day mortality rate, which can arise through the aforementioned complications.
Nilas Young, chief of cardiothoracic surgery at UC Davis Medical Center and a study co-author, said it has long been known that aspirin is lifesaving for patients who have heart attacks.
He added: "Now we know that this simple intervention can do the same for patients who undergo certain coronary surgeries. This outcome could lead to new preoperative treatment standards in cardiac medicine."
According to the British Heart Foundation, cardiovascular disease is the biggest killer in the UK and includes conditions such as angina, heart attack and stroke.
Posted by Philip Briggs
Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.